How many of you are on Tracleer? How did you decide to start this treatment? Did your insurance have any influence on the decision?
I was on Tracleer many years ago and found that it magnified my side-effects without having a significant impact on my pulmonary arterial hypertension (PAH). I didn’t have any luck with other ERA’s I tried either. The very expensive epoprostenol infusions and later Revatio helped me most.
Frankly, it makes me uncomfortable to see cost-effective studies. What do you think of this concept? As a patient, I’m only interested in the medications’ objective efficacy. But that comes from a place of privilege with insurance that covers the majority of my medication costs. In other countries where access to treatments is limited, cost may play a role in patients’ decisions.
Does the cost of different treatments affect you? How so?
Pulmonary Hypertension News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.